PapersPMID:12499992
Dietary threonine reduces plasma phenylalanine levels in patients with hyperphenylalaninemia.
What moved
1 findingHow to read these marks →- Decreases plasma phenylalanine concentration
very limited
“Dietary THR supplementation of approximately 50 mg/kg per day resulted in a significant decrease of plasma PHE levels ( P = 0.0234).”
- Study
- crossover
- Duration
- 8 weeks
- Dose studied
- oral L-threonine (THR), approximately 50 mg/kg per day for 8 weeks, against a similar amount of maltodextrin as placebo
- Population
- Patients with hyperphenylalaninemia, placebo-controlled crossover (8 weeks supplement, 8 weeks wash-out, 8 weeks crossed over), on special PHE-free amino acid mixture diets
Study record
- Design
- crossover trial
- Species
- human
- Population
- Patients with hyperphenylalaninemia on special PHE-free amino acid mixture diets
- Participants
- 12
- Comparator
- placebo
- Duration
- 56 days
- Endpoints measured
- 2
- Declined
- this platform holds no node for the endpoint